Continue to Intralinks Portal

Mr. Kumasi Bangudi-Smothers is an Associate in Spring Mountain Capital, LP’s West Harlem Innovation Network Group.

Prior to joining SMC, Kumasi was an associate at Techstars, LLC, where he and his team partnered with JPMorgan to invest in Black, Latinx, Indigenous, and Women owned businesses. At Techstars, Kumasi was responsible for evaluating prospective startups, assessing market dynamics and competitors, and conducting due diligence on investment opportunities across a range of sectors. He also ultimately served on the investment committee alongside several industry experts. Kumasi was first introduced to impact investing through his role as a Supplier Diversity & Analytics co-op at Bristol Myers Squibb, where aided BMS in pursuing their goal to spend $1 billion dollars supporting small Minority / Women-Owned Business Enterprises (M/WBE). Kumasi graduated from Howard University with a B.A in Finance where he was a Thurgood Marshall College Fund Scholar and Executive Leadership Council Scholar.

Mr. Bermingham joined SMC in 2017 as an Investment Specialist focused on business development efforts across all of the firm’s product lines. Prior to joining SMC, he served as a Managing Director of Pulteney Street Premier, developing a structured investment strategy for offshore deferred compensation of hedge fund general partners, and as Managing Partner of Ten Pine Advisors, advising companies on capital market strategies. Mr. Bermingham began his career at Merrill Lynch as a municipal bond specialist and has held senior roles at Lehman Brothers, Thomas Weisel Partners, Spencer Trask Ventures, Jesup & Lamont Securities and Butler Capital involving both traditional and alternative assets. He received his B.A. in Economics from Hobart College.

Ms. Lucy Cai is a WHIN Life Science Research Fellow at Spring Mountain Capital where she assists the Life Sciences team on a wide range of projects. Ms. Cai also serves as a Research Fellow in the inaugural cohort of the City Innovations Collaborative (CInC) at The City College of New York. At the CInC, Ms. Cai aids in the early development and commercialization of university-generated intellectual property, assists in operational programming of the Masters in Translational Medicine, mentors current students, and conducts industry research in the Life Sciences sector.

Ms. Cai graduated from The City College of New York with a Bachelor’s degree in Biomedical Engineering and a Master of Sciences in Translational Medicine.

Ms. Chang is the Fund Controller at SMC and joined the firm in 2021. She was previously at SMC from July 2007 until March 2010, and from August 2011 until June 2020, most recently as an Accounting Manager. Ms. Chang previously served as a Manager at SS&C Technologies, a Senior Accountant at Cerberus Capital Management, L.P. and a Senior Audit Associate at Rothstein Kass & Company. While at Rothstein Kass, she was responsible for performing audit and tax work on various hedge funds. Ms. Chang received an M.S. in Accountancy from Baruch College and a B.S. in Business Administration from Wichita State University. She is a member of the American Institute of Certified Public Accountants.

Ms. Dzienius is SMC’s Office Manager and Administrative Assistant and joined the firm in 2019. Her prior experience includes over six years in both the retail and hospitality industries, including operational experience opening and managing multiple locations. She received her B.S. in Business Management from the Fashion Institute of Technology.

Ms. Moji Fagbemi is SMC’s Client Relations Associate and joined the firm in 2021. She was most recently at Goldman Sachs, where she supported multiple executives within the private wealth management division. Previously, she was a Finance Specialist, resolving issues of NYC’s private and commercial property owners; a Client Service Specialist in insurance and risk management; and she spent a decade working in Management and Human Resources at a multinational clothing retailer. Moji graduated from CUNY Brooklyn College with a double major in Pre-Law and History.

Mr. Fiore is a Vice President and joined SMC in 2010. He received a B.S. in Mathematics from Drexel University. While at Drexel, he worked on the trading floor with both the energy and convertible bond Groups at Susquehanna International Group. Prior to this, Mr. Fiore was enlisted in the U.S. Air Force as a Precision Measurement Equipment Technician, and calibrated and repaired electronic equipment.

Mr. Pavel Greenfield is currently head of the Education Technology practice in SMC’s Opportunity Zone group. He is also the founder of Lemma, an innovative education technology startup that develops educational content and has served thousands of students across the globe. Since joining SMC in 2001, Pavel has held a range of positions across the firm from technical architecture and cybersecurity to risk and quantitative analysis.

Pavel is also an Associate Professor of Mathematics at Drexel University. He was employed by Merrill Lynch & Co., Inc. from July 1996 to February 1999. While in the Management Science area, he contributed to the calculation of the ML Baby Boom Index, as well as the creation and maintenance of a system for the construction of optimal portfolios of mutual funds. Upon transferring to the Global Risk Management area, he supervised the development of the VaR system, assisted in testing derivatives pricing models, and was instrumental in designing the new risk system S2 for monitoring market exposures across all trading groups.

Pavel received a Ph.D. in Mathematics from the Massachusetts Institute of Technology and a B.A. in Physics from Princeton University.

Current Portfolio Company Board Seats:

• Lessonbee

Ms. Laura Hamilton is an Associate in SMC’s Growth Equity Group and joined the firm in 2022. Prior to joining SMC, Laura was an Analyst at Alvarez & Marsal in their Private Equity Performance Improvement Group, where she focused on cost optimization and operational due diligence projects across the Facilities Services, Consumer Goods, and Staffing Services sectors. Laura graduated from the University of Pennsylvania with a B.A. in Politics, Philosophy, and Economics.

Current Portfolio Company Observer Seats:

• EverWash
• Keen Decision Systems
• Koneksa Health
• Splash

‍

Ms. Petra Hansen co-heads the Private Capital Funds Group, heads product development for Private Capital and is a member of its Investment Committees. She is responsible for managing the Private Capital portfolios, sourcing investments, due diligence and fundraising.

Petra joined SMC in 2015 from HealthpointCapital, LLC, a New York-based private equity firm focused on the Musculoskeletal Healthcare sector. Prior to Healthpoint, Petra was an analyst at White Mountains Reinsurance Group, where she helped execute M&A transactions.

Currently, Ms. Hansen is a director of SMC Digital Inc. and serves on the board of Rinvest Digital AG, a European private investment firm. She is an advisor to Armstrong Robotics, a Silicon Valley-based robotics start-up. Previously, she was an advisor to Newsle, Inc., a social media company, which was acquired by LinkedIn in 2014 and is now part of Microsoft, Inc.

Ms. Hansen began her career at the Dartmouth College Endowment office where she was an Assistant Investment Officer responsible for the management of the College’s private equity portfolio. Ms. Hansen received an M.B.A. from the Amos Tuck School at Dartmouth and a B.A. in Economics from UCLA.

Mr. Gregory P. Ho is the President of SMC and one of its founding partners, as well as the head of the Opportunity Zones Group. Prior to joining SMC in 2001, Greg was a Principal and Chief Financial Officer of McKinsey. During his 16 years with McKinsey, he led the financial and tax planning for the firm and led McKinsey’s expansion into over 30 new countries. Greg also was a member of the firm’s Investment Committee and a Trustee of McKinsey’s Profit-Sharing Retirement Plan (PSRP). In these capacities, he oversaw the identification, evaluation, and selection of traditional and alternative asset managers and investments for over $1 billion of partner and employee assets and, with several other McKinsey partners, co-founded the McKinsey Investment Office. After leaving McKinsey in 1998 and prior to joining SMC, Greg was a private investor and consultant to several prominent NYC financial services companies and technology start-ups. Prior to joining McKinsey, he was associated with the law firm of Donovan Leisure Newton & Irvine.

Greg is currently a member of the Advisory Board of Venture for America and the Advisory Council for Columbia Law School’s Center for Public Research and Leadership. He received a J.D. from Columbia Law School and a B.S., with honors, in Administrative Science from Yale College. He is a member of the New York Bar and the California Bar.

Current Portfolio Company Board Seats:

• Allyx Therapeutics
• Athari Recruiting
• AtlasXomics
• Episteme Prognostics
• ReNetX Bio
• WHIN NHRE

Ms. Lynn Hui is SMC’s Controller and joined the firm in 2009. She was formerly a Financial Analyst in the Financial Planning & Analysis department at McKinsey & Company, Inc., an international management consulting firm. During her 30 years at McKinsey, from 1988 to 2008, Lynn managed global budget and forecasting and contributed to monthly financial reports and various targeted reports, models and databases. From 1978 to 1987, Lynn was an International Tax Accountant and assisted with U.S. Federal and State tax returns. Lynn received a B.B.A. in Public Accounting from Pace University and is a member of the American Institute of Certified Public Accountants.

Jack Januszewski is a Vice President at Spring Mountain Capital, LP’s West Harlem Innovation Network group, where he co-leads the Education Technology practice.

Prior to joining SMC, Jack was the President and COO of Lemma, Inc., an online mathematics education technology company based in Philadelphia. Under his leadership, Lemma partnered with dozens of college access organizations across the country to provide high-quality education technology solutions and college preparatory materials to thousands of students. Lemma has and continues to provide high-quality college preparatory materials to thousands of first-generation-to-college students across the country and mathematics content to students around the world.

Jack received B.A.s, cum laude, in History and Romance Languages from Boston College. He regularly works with and mentors for organizations such as Techstars, Venture for America, and StartEd to guide early-stage startup companies. He also serves as Vice President of the Board of Governors at Blair Academy in New Jersey and a Trustee of the Katama Airfield Trust on Martha’s Vineyard.

Current Portfolio Company Board and Observer Seats:

• Lessonbee

‍

Ms. Lawhorne is a Vice President in SMC’s Growth Equity Group and joined the firm in 2023. Prior to joining SMC, Ms. Lawhorne was an Associate at Apollo Global Management in their Private Equity Group specializing in the energy transition and industrials sectors, where she was involved in all stages of investment processes and portfolio company management. She began her career as an investment banking analyst at Credit Suisse in New York. She is also a junior board member of the nonprofit FAN4Kids. Ms. Lawhorne graduated summa cum laude from Tulane University with a BSM in Finance.

Ms. Miriam Minkowitz is a WHIN Life Science Research Fellow at Spring Mountain Capital, where she assists the Life Sciences team on a wide range of projects. Miriam is also an Investigative Fellow at the City Innovations Collaborative (CInC) at The City College of New York. At CInC, where she contributes to the early development and commercialization of university-generated intellectual property, assists in the functional programming of the Masters in Translational Medicine platform , mentors current students, and conducts industry research in the Life Science sector. Her dual interests in science and community impact motivates her to learn more about new technologies, and work to advance the state of their respective fields with purpose.

Miriam received her Bachelor’s in Science from Touro College with honors and her Master's of Translational Medicine from the Grove School of Engineering at The City College of New York.

‍

Dr. Mozes is a Consultant and joined SMC in 2001. He is presently a Professor of Accounting at Fordham University, where he has taught a variety of courses in accounting and finance since 1989. From May 2000 to May 2001, he was Director of Research at StarMine Corporation. Dr. Mozes has also taught at New York University’s Stern School of Business and at Baruch College-CUNY and has presented numerous papers at academic and professional conferences. He has also published extensively on a wide range of investment subjects. Dr. Mozes received a Ph.D. in Accounting from New York University, a Masters in Statistics/Operations Research from New York University and a B.A. in Economics from Touro College.

Mr. Orchard is a Managing Director and heads the Total Return Group. Jason has been with SMC since 2004 and has served as a Managing Director since 2008.  During his time at SMC, he has served as Investment Analyst, Chief Financial Officer, and Portfolio Manager.  In 2007, he led the firm’s initial efforts into special situation and thematic investments that have become the foundation of the SMC Total Return Fund.  Today, he manages the investment efforts of the SMC Total Return Fund and serves on the Investment Committees for the SMC Total Return Fund, SMC Private Capital Fund, and West Harlem Innovation Fund.  Prior to joining SMC in 2004, he was a Senior Analyst for Rutherford Asset Management LLC, which actively managed an $800 million hedge fund- of- funds portfolio for a private family office. Jason has also been associated with Stern Stewart & Company as a Senior Analyst in the Financial Institutions Group and Arthur Andersen, L.L.P. as a Senior Consultant in the Strategy, Finance, and Economics Group. Jason graduated with honors from Villanova University with a B.S. in Finance and holds the Chartered Financial Analyst^® designation.

Currently serving on the Board of Directors of the following companies:

• ProSomnus, Inc (OSA)
• Micropore Incorporated

Mr. Jason Rifkin is a Managing Director in SMC’s Opportunity Zone group, where he co-leads WHIN’s Life Sciences practice. As a Managing Director, Jason leads discovery and diligence on WHIN’s investments in Life Sciences companies focused on neurodegenerative diseases, oncology, biologic, and small molecule therapeutics, drug delivery, and medical devices. Jason has extensive experience in developmental stage life science and healthcare companies. Across his career he has managed all aspects of company operations. Prior to joining SMC’s WHIN group, Jason held executive roles at PhageNova Bio, Cage Pharma, and Delcath Systems, Inc.

Before his career in the Life Sciences, Jason practiced law with Fox Rothschild as an Associate in the Corporate Department/-Pharmaceutical and Biotechnology Group. Jason received a Bachelor’s degree from the University of Pennsylvania, a Law Degree from Northeastern University School of Law, and a Masters of Biotechnology from the University of Pennsylvania, School of Engineering and Applied Sciences.

Representative Past and Portfolio Company Board and Observer Seats:

• Allyx Therapeutics
• Episteme Prognostics

Ms. Tara Sharp is the General Counsel of SMC. Before joining SMC, Tara was an associate in the Finance Department at Schulte Roth & Zabel LLP. Prior to joining Schulte Roth and Zabel LLP, Tara was an associate in the Credit and Mergers and Acquisitions Departments of Simpson Thacher & Bartlett LLP, and served as law clerk for the Honorable Richard Conway Casey, in the Southern District of New York. Tara received a J.D., cum laude, from Fordham University School of Law and a B.A. from The College of William and Mary, and is a member of the New York Bar.

Mr. Michael J. Smith is a Senior Portfolio Manager and directs SMC FIM’s Separately Managed Account Program. He has over 25 years of experience in the municipal fixed income market and has been involved in all facets of the separately managed account business, including portfolio management, client servicing, accounting, performance reporting and trading. Michael has over 20 years of experience trading all sectors of municipal securities in all 50 states. Michael joined SMC FIM from U.S. Trust Company as Vice President on the municipal trading desk, where he was instrumental in the conversion of their electronic order entry and trading platform system for private banking clients. Prior to joining U.S. Trust Company, Michael was employed by Merrill Lynch Investment Managers as an Assistant Vice President, and bond trader for separately managed accounts. During this period, the assets of the privately managed accounts increased from $2 billion to over $6 billion. Michael received a B.S. in Accounting from Temple University. He is a member of the New York Society of Security Analysts.

Mr. Kenneth Soll is a Principal in SMC’s Growth Equity Group and has been with the firm since 2017. Kenneth was previously at Bank of America Merrill Lynch where he focused on transactions in the technology, media and telecommunications sectors. Kenneth graduated from Vanderbilt University with a B.S. in Human and Organizational Development.

Current Portfolio Company Board and Observer Seats:

• Aware
• Eyrus
• Thentia
• Recess

Representative Past Portfolio Company Board and Observer Seats:

• 180 Health Partners
• OpenSlate
• RiskSense

Mr. John L. Steffens is the Founder and Senior Managing Director of SMC, co-head of SMC’s Private Capital Funds Group and is a member of each SMC Fund’s Investment Committee. Prior to founding SMC in 2001, Mr. Steffens spent 38 years at Merrill Lynch & Co., Inc., where he held numerous senior management positions, including President of Merrill Lynch Consumer Markets, Vice Chairman of Merrill Lynch & Co., Inc., and Chairman of its U.S. Private Client Group. Under his leadership, the Private Client Group experienced tremendous growth, increasing assets under management from $200 billion to $1.6 trillion. Mr. Steffens also served on the board of directors of Merrill Lynch & Co., Inc. from April 1986 until July 2001.

Mr. Steffens currently serves on the boards of directors of RepairSmith, and AtlasXomics Inc., and as Chairman of the Board of Directors of SMC Alternatives Inc. He also serves on the advisory board of StarVest Partners. In addition, he is currently National Chairman Emeritus of the Alliance for Aging Research. Previously, Mr. Steffens served as Chairman of the Securities Industry Association (now the Securities Industry and Financial Markets Association, or SIFMA), as a Trustee of the Committee for Economic Development, and as a member of the Board of Overseers of the Geisel School of Medicine at Dartmouth. In 2010, Mr. Steffens was the recipient of the Billie Jean King Contribution Award from the Women’s Sports Foundation.

Mr. Steffens received a B.A. in Economics from Dartmouth College and also completed Harvard Business School’s Advanced Management Program.

Mr. John Wang is Managing Director in SMC’s Opportunity Zone Group, where he leads WHIN’s Food and Beverage practice. John brings his expertise in the industry to analyzing the commercial viability of early-stage food and beverage concepts. John is also uniquely qualified to assess the needs and competencies of founding teams as well as their strategic fit in the WHIN ecosystem.

John is the founder of the Queens Night Market, a uniquely affordable, family-friendly community event that has attracted nearly two million visitors since it debuted in 2015. The hugely popular and critically acclaimed event has helped launch more than 350 new businesses in New York City and has represented over 90 countries through its food offerings.

John graduated from Yale Law School and the Yale School of Management. He earned his undergraduate degrees at the University of Michigan.

Mr. Kenneth Wang is a Managing Director in SMC’s Opportunity Zones group, where he co-leads WHIN’s Life Sciences practice. Ken  currently serves as CEO of AtlasXomics, Inc., a life science tools company based in New Haven, Connecticut. Ken has worked in the chemical and life sciences industry as a process research engineer, investment banker, and entrepreneur for over 30 years, and has also consulted for SMC on several Life Sciences investments.

A chemical engineer by training, Ken has a range of experience in polymers and advanced materials with microscopic and nanoscale features. After gaining a broad range of investment banking experience at JPMorgan and CS First Boston, he became an independent financial advisor to multinationals (Mitsubishi Corporation, ITOCHU, GE Plastics, Marubeni, Mitsui) as well as to entrepreneurial small companies.

Ken holds B.S. and M.S. degrees in Chemical Engineering from Cornell University and the Massachusetts Institute of Technology, respectively, and an MBA from The Wharton School of the University of Pennsylvania.

Current Portfolio Company Board and Observer Seats:

• AtlasXomics

Mr. Jamie Weston is a Managing Director in SMC’s Growth Equity Group and has been with the firm since 2011. Jamie was previously a Partner at The Wicks Group of Companies, a private equity firm with close to $1 billion under management, focused on selected segments of the information, education, and media industries. During his 15 years at Wicks, he was an integral part of its investment and management activities, and served on the board of directors of many of its portfolio companies. While at Wicks, he directly structured and negotiated more than 20 acquisitions and divestitures and worked on more than 40 additional closed transactions. Prior to Wicks, Jamie  worked at IBJ Whitehall Bank & Trust Company and National Westminster Bancorp, where he completed leveraged financings. Jamie  received his M.B.A. from Fordham University and graduated cum laude from Drew University with a B.A. in Economics.

Current Portfolio Company Board and Observer Seats

• Aware
• Eyrus
• Keen Decision Systems
• Thentia

Representative Past Portfolio Company Board and Observer Seats

• 180 Health Partners
• Activate Healthcare
• Giga-tronics
• Iron Solutions
• Maven
• OpenSlate
• PNBK Holdings
• Prevalent
• SimpleReach
• WhipTail Technologies
• Ziften

Mr. Raymond Wong is a Managing Director and heads the Growth Equity Group. Prior to joining SMC in 2007, Raymond was a senior Managing Director in the Investment Banking Division of Merrill Lynch & Co., Inc. While at Merrill Lynch, Raymond served on the Investment Banking Operating Committee and as Chairman of the Corporate Finance Committee. During his 25 years at Merrill Lynch, he had responsibility for the corporate finance relationships for many of the firm’s largest corporate clients. Raymond served on the board of directors of Alleghany Corporation and previously served on the board of directors of Merrill Lynch Ventures, LLC. Raymond received his M.B.A. with honors from Harvard Business School and graduated summa cum laude from Yale College with a B.A. in Political Science.

Current Portfolio Company Board and Observer Seats

• Chimerix
• EverWash
• Genomenon
• Koneksa Health
• Recess
• Splash
• Vergent Bioscience

Representative Past Portfolio Company Board and Observer Seats

• Activate Healthcare
• Doctor.com
• IsoPlexis
• Oncoceutics
• RiskSense
• SimpleReach
• WhipTail Technologies

‍

Mr. Kris Woo is the firm’s Chief Financial Officer and joined SMC in 2010. He was formerly a Senior Audit Associate in the financial services department at McGladrey & Pullen, LLP. During his three and a half years with McGladrey, he was responsible for performing audit, tax and administrative services for a variety of hedge funds. Kris received a B.A. in Economics and a B.A. in Accounting and Information Systems from Queens College. He holds the Chartered Financial Analyst® designation and is a member of the American Institute of Certified Public Accountants.